Description: The proliferating cell nuclear antigen (PCNA) is a 36 kDa molecular weight protein also known as cyclin. The protein has also been identified as the polymerase-associated protein and is synthesized in early G1 and S phases of the cell cycle. In early S phase, PCNA has a very granular distribution and is absent from the nucleoli. At late S phase, PCNA is prominent in the nucleoli. In cells fixed with organic solvents, PCNA is seen to be strongly associated in the nuclear regions where DNA synthesis is occurring, whereas in cells fixed with aldehydes the staining is more diffuse but intense and occurs throughout the cell cycle. This is due to the presence of two basic forms of the PCNA protein, a soluble form sensitive to organic fixation and not involved in replication, and a second form that is insoluble and is associated with ongoing DNA synthesis. PCNA is a very conserved protein present not only in animal but also in plant cells.
Primary Antibody
Name: PCNA Antibody |
Clone: PC-10, Mouse anti-Rat |
Supplier: Dako |
Catalog Number: M0879 |
Dilution: 1:1500 using IHC-TekTM Antibody Diluent (Cat# IW-1000 or IW-1001) to reduce background and unspecific staining and serum blocking step is NOT needed. |
Incubation Time/Temp: 60 min/room temperature |
Device: IHC-TekTM Epitope Retrieval Steamer Set (Cat# IW-1102) |
Buffer/pH value: IHC-TekTM Epitope Retrieval Solution (Cat# IW-1100) |
Heat/Cool Temperature: 95-100 ºC/room temperature |
Heat/Cool Time: 20 minutes/20 minutes |
Standard Method: ABC Method or LSAB Method |
Enhanced Method: Polymeric Methods |
Reagent: DAB |
Incubation Time/Temperature: 1-3 minutes/room temperature |
Reagent: Mayer's Hematoxylin |
Staining Time: 30 seconds |
Staining Pattern: Nuclear |
Images: Search image |
Species Reactivity: Rat |
Fixation: Formalin fixed paraffin sections |
Positive Control: Skin, colon cancer |
Negative Control: Omit primary antibody, isotype control, absorption control |
Blocking: 2-5% normal serum to reduce unspecific background staining; 0.5-3% H2O2 to block endogenous peroxidase activity; avidin/biotin to block endogenous biotin activity if necessary |
References: